
July 18, 2024
RegMed Investors’ (RMi) pre-open: after a sector crash, is there a make book on some upsiders
July 18, 2024
RegMed Investors’ (RMi) pre-open: after a sector crash, is there a make book on some upsiders
July 17, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector equities tank
July 17, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector equities tank
July 17, 2024
RegMed Investors’ (RMi) pre-open: calling the top and lower pricing going forward?
July 17, 2024
RegMed Investors’ (RMi) pre-open: calling the top and lower pricing going forward?
July 16, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector equities ride the waves
July 16, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector equities ride the waves
July 16, 2024
RegMed Investors’ (RMi) pre-open: watch the topography of share pricing
July 16, 2024
RegMed Investors’ (RMi) pre-open: watch the topography of share pricing
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors